United States · FDA National Drug Code directory

Eltrombopag

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
31722-301_315730ec-c40c-af1a-e063-6294a90a010f
Product NDC
31722-301
Form
POWDER, FOR SUSPENSION
Composition / generic term
Eltrombopag olamine
Labeler
Camber Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20250513
Source listing expiry
20261231

Source-listed ingredients

  • ELTROMBOPAG OLAMINE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 CARTON in 1 KIT (31722-301-32) / 30 PACKET in 1 CARTON (31722-301-31) / 1 POWDER, FOR SUSPENSION in 1 PACKET (31722-301-25) · 31722-301-32

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →